Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-5-28
pubmed:abstractText
The purpose of this study is to investigate the efficacy of an intensive chemotherapy induction regimen followed by myeloablative chemotherapy and autologous hematopoietic stem cell rescue (AHSCR) in children with newly diagnosed ependymoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1545-5009
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
34-40
pubmed:dateRevised
2009-1-12
pubmed:meshHeading
pubmed-meshheading:16874765-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16874765-Brain Neoplasms, pubmed-meshheading:16874765-Carboplatin, pubmed-meshheading:16874765-Child, pubmed-meshheading:16874765-Child, Preschool, pubmed-meshheading:16874765-Cisplatin, pubmed-meshheading:16874765-Combined Modality Therapy, pubmed-meshheading:16874765-Cyclophosphamide, pubmed-meshheading:16874765-Disease-Free Survival, pubmed-meshheading:16874765-Ependymoma, pubmed-meshheading:16874765-Etoposide, pubmed-meshheading:16874765-Female, pubmed-meshheading:16874765-Follow-Up Studies, pubmed-meshheading:16874765-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:16874765-Humans, pubmed-meshheading:16874765-Infant, pubmed-meshheading:16874765-Male, pubmed-meshheading:16874765-Methotrexate, pubmed-meshheading:16874765-Neoplasm Recurrence, Local, pubmed-meshheading:16874765-Thiotepa, pubmed-meshheading:16874765-Transplantation, Autologous, pubmed-meshheading:16874765-Treatment Outcome, pubmed-meshheading:16874765-Vincristine
pubmed:year
2007
pubmed:articleTitle
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
pubmed:affiliation
Department of Pediatric Hematology/Oncology, Children's Hospital Los Angdes, Neural Tumors Program, Los Angles, CA 900 27, USA. szacharoulis@chla.usc.edu
pubmed:publicationType
Journal Article